In the second part, the discussion turns to emerging DED therapies that target tear function and ocular surface homeostasis.
The panel reviews the mechanisms, efficacy, and tolerability of novel treatments, including perfluorohexyloctane (Miebo), ...
The MarketWatch News Department was not involved in the creation of this content.-- The first VisiPlate surgery in the US for the SAPPHIRE Trial was performed by Dr. Snyder of Sac ...
Abstract: In ophthalmic surgery, especially in posterior segment procedures, clinicians face significant challenges, like the inherent tremor of the surgeon’s arm, restricted visibility, and heavy ...
Approval underscores Amneal’s advanced sterile manufacturing capabilities and expansion within complex ophthalmic therapies; Launch expected in ...
Amneal Pharmaceuticals (AMRX) announced the FDA has approved the company’s cyclosporine ophthalmic emulsion 0.05%, a sterile, preservative-free ...
They're prescribed to bring much needed relief, but a new report indicates they might not have delivered what was promised. With harsh winds outdoors and dry heat indoors, winter conditions create the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback